Wikidata

(Q34278437)

English

Bortezomib with chemotherapy is highly active in advanced B-precursor acute lymphoblastic leukemia: Therapeutic Advances in Childhood Leukemia & Lymphoma (TACL) Study

scientific article

In more languages

Statements

title
Bortezomib with chemotherapy is highly active in advanced B-precursor acute lymphoblastic leukemia: Therapeutic Advances in Childhood Leukemia & Lymphoma (TACL) Study (English)
1 reference
stated in
Europe PubMed Central
PubMed ID
22653976
retrieved
1 August 2017
author name string
Yoav H Messinger
series ordinal
1
1 reference
stated in
Europe PubMed Central
PubMed ID
22653976
retrieved
1 August 2017
Richard Sposto
series ordinal
3
1 reference
stated in
Europe PubMed Central
PubMed ID
22653976
retrieved
1 August 2017
Jeannette van der Giessen
series ordinal
4
1 reference
stated in
Europe PubMed Central
PubMed ID
22653976
retrieved
1 August 2017
Elena Eckroth
series ordinal
5
1 reference
stated in
Europe PubMed Central
PubMed ID
22653976
retrieved
1 August 2017
Jemily Malvar
series ordinal
6
1 reference
stated in
Europe PubMed Central
PubMed ID
22653976
retrieved
1 August 2017
Bruce C Bostrom
series ordinal
7
1 reference
stated in
Europe PubMed Central
PubMed ID
22653976
retrieved
1 August 2017
Therapeutic Advances in Childhood Leukemia & Lymphoma (TACL) Consortium
series ordinal
8
1 reference
stated in
Europe PubMed Central
PubMed ID
22653976
retrieved
1 August 2017

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    Retrieved from "https://www.wikidata.org/w/index.php?title=Q34278437&oldid=1901881266"